The investigators said that the trial data showed potentially clinically meaningful improvements in both progression-free survival and overall survival in pre-specified subgroups of patients based on the baseline inflammatory biomarker, hs-CRP, as well as other biomarker-defined subgroups.
Read More
FDA Panel Votes to Recommend Pfizer-BioNTech COVID-19 Vaccine in Children 5 to 11 Years of Age
October 27th 2021No timetable was set for the FDA to decide on an official EUA designation for the Pfizer-BioNTech vaccine in children 5 to 11 years of age, however a decision is expected within the next few days.
Read More